When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Syndax Pharmaceuticals press release (NASDAQ:SNDX): Q1 GAAP EPS of -$0.63. Total operating expenses of $36.85M. Research and development expenses of $30.02M. For Q2: Research and development expenses are expected to be $30M to $35M, and total operating expenses are expected to be $38M to $42M. For FY22: Research and development expenses are expected to be $130M to $140M, and total operating expenses are expected to be $160M to $170M.